Causes of male infertility: medical, hormonal and lifestyle factors

Understand what can affect sperm production, hormones and ejaculation—and how a proper assessment helps identify your next step.

Peter Grice
Medically reviewed by
Peter Grice, Clinical Lead
Table of contents

Male infertility can involve sperm production or movement, a blockage, hormones, erections or ejaculation. Genetics, medical treatment and some exposures can also contribute. Several factors may be involved.

A proper assessment combines your history, examination, semen analyses and selected tests. It helps distinguish a treatable cause from a risk factor such as smoking, obesity or excessive alcohol.

Heracles brings together expertise in male fertility, urology and hormones. Co-founders Professor Tet Yap and Professor Suks Minhas specialise in men’s reproductive health; Clinical Lead Peter Grice oversees our clinical pathways. Meet the Heracles clinical team.

Problems with sperm production or function

The testicles produce sperm through a process controlled by hormones from the brain and pituitary gland. A problem in the testicles, hormonal signalling or sperm-development process can lead to:

  • azoospermia: no sperm detected in the ejaculate
  • oligozoospermia: a low sperm concentration
  • asthenozoospermia: reduced sperm movement
  • teratozoospermia: fewer sperm meeting strict normal-shape criteria
  • a combination of abnormalities.

These terms describe the result, not the cause. A repeat semen analysis and clinical assessment help determine what needs attention.

Testicular causes

Sperm production may be affected by a condition present from birth or acquired later. Relevant examples include:

  • one or both testicles not descending into the scrotum in childhood
  • previous testicular torsion or significant trauma
  • infection or inflammation of a testicle, including post-pubertal mumps orchitis
  • testicular cancer or surgery involving a testicle
  • chemotherapy or radiotherapy
  • a genetic or chromosomal condition
  • impaired testicular function associated with another medical condition.

These histories justify earlier fertility assessment. NICE recommends referral at presentation when either partner has a known or suspected cause or a predisposing history; there is no requirement to try for a year first.

Obstruction: when sperm cannot reach the ejaculate

Sperm may be produced but prevented from entering the semen. This is called obstructive azoospermia when no sperm appear in the ejaculate because of a blockage or absent duct.

Potential causes include:

  • previous vasectomy
  • scarring after infection, inflammation or surgery
  • injury to the epididymis or vas deferens
  • congenital absence of the vas deferens, which can be associated with variants in the CFTR gene
  • obstruction of the ejaculatory ducts.

Semen volume, examination findings and hormone results can help distinguish an obstruction from reduced sperm production. Ultrasound or genetic testing is used when clinically indicated rather than for every abnormal count.

Hormonal causes

The hypothalamus and pituitary gland signal the testicles through luteinising hormone and follicle-stimulating hormone. Disruption at any level may reduce sperm production.

Possible causes include hypogonadotropic hypogonadism, pituitary disease, raised prolactin and primary testicular failure. Symptoms such as reduced sexual desire or changes in secondary sexual characteristics may provide clues, but some men have few symptoms.

Morning testosterone, gonadotrophins and selected tests help clarify the hormone pattern. Replacement testosterone can suppress the signals needed for sperm production and is not a treatment for male infertility.

Varicocele

A varicocele is an enlargement of veins around the testicle. It is common, and many men with a varicocele are fertile. A clinically detectable varicocele can, however, be associated with reduced semen parameters in some men.

Current NICE guidance says radiological or surgical treatment may be considered when the varicocele is found on clinical examination, the couple is trying to conceive spontaneously and semen parameters are reduced. The partner's fertility and the couple's timeframe should also be taken into account. Treating an incidental or ultrasound-only finding is not automatically beneficial.

Erections, ejaculation and sexual factors

Sperm production can be normal while delivery is impaired. Fertility may be affected by:

  • erectile dysfunction that prevents vaginal intercourse
  • anejaculation, where no semen is released
  • retrograde ejaculation, where semen passes into the bladder
  • pain, anatomical problems or difficulty having intercourse
  • some neurological conditions, diabetes, surgery or medicines that affect ejaculation.

The cause determines the least invasive option. Assessment may include a sexual and medication history and, when retrograde ejaculation is suspected, testing urine after orgasm for sperm.

Genetic causes

Genetic investigation is targeted to clinical findings and the severity of the semen abnormality. Under NICE guideline NG257:

  • Y-chromosome microdeletion testing is recommended for idiopathic azoospermia or a sperm concentration below 1 million per ml
  • CFTR testing is recommended when idiopathic obstructive azoospermia, an abnormal vas deferens or both are suspected
  • karyotyping is recommended for idiopathic azoospermia and may be considered when sperm concentration remains below 5 million per ml
  • genetic counselling should be offered when a relevant genetic defect is identified.

The purpose is not only to explain the result. Some findings alter the probability of retrieving sperm or indicate a chance of passing a condition to a child.

Medicines, drugs and medical treatment

NICE advises clinicians to ask specifically about prescription medicines, over-the-counter products and recreational drugs. Examples named in the guideline include testosterone-replacement therapy, finasteride, GLP-1 receptor agonists, non-steroidal anti-inflammatory drugs, anabolic steroids and cannabis. Inclusion on that list does not mean every product causes infertility in every user; it means the potential effect and the reason for treatment should be reviewed.

Other histories with a recognised fertility risk include chemotherapy, pelvic radiotherapy and some surgery. Sperm freezing should be discussed as early as possible before a medical treatment likely to cause infertility.

Never stop prescribed medicine without the clinician who manages it. For some conditions, stopping abruptly presents a greater health risk, and a suitable alternative may require planning.

Lifestyle and environmental factors

Lifestyle changes cannot correct every cause, but several factors warrant discussion:

  • Smoking: associated with reduced semen quality, although NICE notes that its effect on male fertility itself remains uncertain.
  • Alcohol: excessive intake can harm semen quality. Intake within the UK low-risk limit of 14 units a week, spread across several days, is unlikely to affect semen quality according to NICE.
  • Body weight: a BMI of 30 kg/m² or above is associated with an increased risk of reduced male fertility.
  • Scrotal heat: elevated scrotal temperature is associated with reduced semen quality, but evidence that loose underwear improves fertility is uncertain.
  • Work exposures: some pesticides, solvents, metals, heat or radiation exposures may be relevant. The substance, dose and protective controls matter.
  • Recreational and performance-enhancing drugs: anabolic steroids can markedly suppress sperm production. Other drug use should be disclosed so that advice is specific and non-judgemental.
Area Examples Assessment may include
Sperm productionPrevious undescended testicle, torsion, orchitis, cancer treatment or genetic conditionRepeat semen analysis, examination, hormones and selected genetic tests
Sperm transportVasectomy, congenital absence of the vas deferens or acquired blockageExamination, semen features, imaging and CFTR testing when indicated
Hormonal signallingPituitary disorder, hypogonadotropic hypogonadism or testicular failureSymptoms, examination, testosterone, gonadotrophins and targeted tests
Sexual function and ejaculationErectile dysfunction, anejaculation or retrograde ejaculationSexual and medication history, examination and selected urine testing
Lifestyle or exposureSmoking, excessive alcohol, obesity, anabolic steroids or occupational hazardsSpecific exposure review rather than assuming it is the sole cause

Why is no cause sometimes found?

Semen analysis measures selected features, and current tests cannot explain every defect in sperm production or function. “Idiopathic male infertility” describes an abnormal fertility assessment without an identified cause. “Unexplained infertility” generally means that standard investigations have not identified a cause in either partner.

NICE advises against sperm DNA-fragmentation testing in the standard UK pathway and against supplements or antioxidants intended to improve sperm DNA integrity. Further testing is most useful when it can change the treatment plan.

Expertise behind your next step

Understanding the cause is the foundation of useful advice. Explore our male infertility treatment guide, meet the Heracles clinical team or contact the Heracles team.